Terumo Tsunami Coronary Stent To Withstand Wave Of DES Entries In Japan
This article was originally published in The Gray Sheet
Executive Summary
Results from European trials of Terumo's drug-eluting stent, using Biosensors' Biolimus A-9 anti-restenotic agent, S-Stent and polymer, will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2004 conference in Washington, D.C. Sept. 29-Oct. 2